The survey polled 326 U.S. adults who had undergone cancer chemotherapy and was sponsored by the National Coalition for Cancer Survivorship and drug maker Sanofi Aventis.
Sixty-three percent of those surveyed said their fears were unjustified and just 14 percent described their side effects as very difficult. Thirty-two percent had a somewhat easy or very easy experience with treatment. But a new study finds those fears may be unfounded.